Opdyta 100mg Nivolumab Injection

Opdyta 100mg Nivolumab Injection is a prescription immunotherapy medication used in the treatment of various cancers, including melanoma, non-small cell lung cancer, kidney cancer, head and neck cancer, and certain types of colorectal cancer. It contains Nivolumab, a monoclonal antibody that works as a PD-1 (programmed death-1) inhibitor, helping the body's immune system recognize and attack cancer cells more effectively. By enhancing the immune response against tumors, Opdyta 100mg Nivolumab Injection can help slow disease progression and improve treatment outcomes in eligible patients. Administered as an intravenous infusion under the supervision of an oncology specialist, it may be used alone or in combination with other cancer therapies. Regular monitoring is essential during treatment to assess response and manage potential immune-related side effects. Patients should use Opdyta 100mg Nivolumab Injection only as prescribed by their healthcare provider.